Ovarian
Featured Articles
(MarketWatch) Nov 19, 2018 - Merck KGaA and Pfizer Inc. said early Monday that the cancer immunotherapy avelumab did not meet the primary endpoints of a phase 3 ovarian cancer trial. The trial, JAVELIN Ovarian 200, tested avelumab both alone and in combination with chemotherapy. It specifically focused on individuals with...
Read Article
(Curetoday.com) Nov 12, 2018 - The FDA has granted a priority review designation to a supplemental new drug application (sNDA) for Lynparza (olaparib) tablets for use as a maintenance therapy in patients with newly-diagnosed, BRCA-positive advanced ovarian cancer who achieved a complete or partial response to standard frontline...
Read Article
Latest Articles
November 20, 2018
November 19, 2018
November 15, 2018
November 13, 2018
November 12, 2018
November 12, 2018
November 12, 2018
November 12, 2018
View More
News Commentary
Editor Image
05 Apr, 2018 | by Winston Wong, PharmD
From a payer perspective, the CMS approval for coverage means that...
View Comment
Editor Image
27 Mar, 2018 | by Thomas Marsland, MD
Who says you can't teach an old dog new tricks..... I am delighted to see...
View Comment
View More
Featured Videos
There are no Ovarian videos.
OBR Blog
There are no Ovarian blog entries.